Team - Shortwave Life Sciences Plc

Our Team

At Shortwave Life Sciences, we’re driven by a focused and experienced leadership team with a wealth of knowledge in drug development, clinical research and strategy, particularly within the psychedelic field.

Board of Directors

Rolf Gerritsen

Executive Chairman

Rolf is an entrepreneurial executive with over 30 years’ experience in strategy, capital markets and business development, with a strong track record of delivering growth and restructuring opportunities for listed and private companies. He has sourced and structured capital across Europe, the USA, Africa, Australia, the Middle East, the Far East and South America, working fluently in four languages. Rolf has advised and served on the boards of international growth companies, with particular focus on natural resources and special situations, where he has developed and implemented creative strategies to unlock value and secure investor support.

⸻

Stephen Murphy

Co-Founder & Executive director

Co-founder of Psych Capital Plc.He founded PSYCH in early 2019 to provide data and intelligence on the emerging psychedelics industry. He is also CEO and co-founder of Prohibition Holdings which owns some of the cannabis industry’s best-known B2B companies and brands including Prohibition Partners, Business of Cannabis, Cannabis Europa and Atalis.

Stephen’s background is in technology, digital media and corporate finance, including roles with Sony Pictures, Unilever and Diageo.

Ron Lipsky

Non-Executive Director

With experience of over 13 years at the highest levels of the plant-based pharma industry, Ron Lipsky has built a global network of trusting relationships in multiple verticals and geographies. As part of the founding team for MGC Pharma, Ron has listed on two exchanges (LSE and ASX) and has a wealth of experience in dealing with public markets and creating pipelines for novel treatments, from clinical studies through to government approvals. A passion for finding pathways to facilitate treatments for underserved indications and an understanding of the necessary mechanisms to leverage globally give him a unique insight to facilitate the vision of Shortwave Life Sciences.

Stephen Molloy

Executive Director

Stephen has spearheaded and established innovative digital, media, and technology businesses across global markets over the last 27 years.

An adept commercial leader, Stephen excels in scaling companies from the ground up. He specializes in identifying emerging technologies and their potential to transform industry and society at large.

Foreseeing the potential of digital property as a major new asset class as early as 2008, Stephen developed innovative business models to realise digital asset value at companies such as Roblox.

Recognizing the transformative impact of blockchain technologies, Stephen earned the Blockchain Business Strategy qualification from Oxford University in 2018. Since then, he has concentrated his research and investments on digital assets fundamental to a more decentralised financial system. Stephen is actively engaged with regulatory developments in the digital asset ecosystem, ensuring any investments adhere to evolving legal frameworks and industry standards.